|
Potential link between Helicobacter pylori seropositivity and macrophage migration inhibitory factor in patients with myocardial infarction underwent primary percutaneous coronary intervention
|
|
| Author:
|
FEYAN ABDULLAH, RUQAYA MOHAMMED GHAREEB TAHER AL-BARZINJI
|
| Abstract:
|
Objective: To determine the possible link between helicobacter pylori (HP) seropositivity and macrophage
migration inhibitory factor (MIF) level in myocardial infarction (MI) patients admitted for primary percutaneous
coronary intervention (PPCI).
Method: This case control study was carried out on 100 MI, 38 stable angina pectoris (SAP), and 38 subjects as
control who admitted to surgical specialty hospital-cardiac centre in Erbil City, Iraq from January to December
2017. Levels of MIF and anti-HP IgG, IgA, and IgM were detected by enzyme linked immunosorbent assay (ELISA).
Polymerase chain reaction (PCR) was done to detect HP 16SrRNA in those samples with IgM+ and/or IgG+IgA+.
Results: Anti-Hp-IgG was positive in 68%, and 55.26% of MI, and SAP patients respectively. A higher proportion
of HP seropositivity was observed in control group (84.21%). Molecular analysis showed no positive result for HP
genomic material. MIF level was insignificantly differed between seropositive and seronegative MI patients (p>0.05).
Seropositive MI group had higher MIF level compared to seropositive and negative control groups (p<0.05).
Conclusion: Result of current study suggested that HP does not have direct role in MI elevated MIF, consequently
demonstrated secondary contribution of HP in the development and progression of MI through low grade
inflammatory response represented by insignificant elevation of MIF, and other inflammatory biomarkers (hsCRP,
and fibrinogen).
|
| Keyword:
|
MIF, PPCI
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2019.11.02.109
|
| Download:
|
Request For Article
|
|
|